| |
| |
|
| Insider
Information: |
Kirk Randal J |
| Relationship: |
10% Owner |
| City: |
Radford |
| State: |
VA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
3,684,697 |
|
|
Indirect Shares
|
67,796,291 |
|
|
| Direct
Value |
$162,251,771 |
|
|
|
Indirect Value
|
$375,195,594 |
|
|
| Total
Shares |
71,480,988 |
|
|
| Total
Value |
$537,447,365 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
14
|
0
|
|
Stock
price went up :
|
6
|
0
|
| Stock
price went down : |
8
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 46.5%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Clinical Data Inc |
CLDA |
Director, 10% Owner |
2011-04-12 |
0 |
2011-04-12 |
0 |
Premium* |
|
|
Halozyme Therapeutics Inc |
HALO |
10% Owner |
2018-08-28 |
3,562,388 |
2018-08-28 |
6,629,464 |
Premium* |
|
|
Precipio Inc |
PRPO |
10% Owner |
2012-02-03 |
0 |
2018-08-28 |
27,151 |
Premium* |
|
|
Precigen Inc |
PGEN |
|
|
0 |
2024-05-02 |
51,557,665 |
Premium* |
|
|
Alaunos Therapeutics |
TCRT |
Director, 10% Owner |
2015-12-31 |
122,309 |
2015-12-31 |
9,570,094 |
Premium* |
|
|
Aquabounty Technologies, Inc. |
AQB |
10% Owner |
2020-02-13 |
0 |
2020-12-17 |
11,917 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
271 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 6 of 11
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HALO |
Halozyme Therapeutics Inc |
10% Owner |
– – • |
2006-09-11 |
4 |
B |
$2.54 |
$8,128 |
I/I |
3,200 |
564,300 |
1.5 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
10% Owner |
– – • |
2006-09-12 |
4 |
B |
$2.58 |
$51,600 |
I/I |
20,000 |
584,300 |
1.5 |
- |
|
| CLDA |
Clinical Data Inc |
Director |
– • • |
2006-09-13 |
4 |
B |
$15.42 |
$471,405 |
I/I |
30,571 |
642,834 |
2.25 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
10% Owner |
– – • |
2006-09-13 |
4 |
B |
$2.50 |
$185,000 |
I/I |
74,000 |
658,300 |
1.5 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
10% Owner |
– – • |
2006-09-14 |
4 |
B |
$2.50 |
$50,000 |
I/I |
20,000 |
678,300 |
1.5 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
10% Owner |
– – • |
2006-09-15 |
4 |
B |
$2.50 |
$256,250 |
I/I |
102,500 |
780,800 |
1.5 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
10% Owner |
– – • |
2006-12-04 |
4 |
B |
$2.86 |
$32,890 |
I/I |
11,500 |
792,300 |
1.5 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
10% Owner |
– – • |
2006-12-05 |
4 |
B |
$2.84 |
$151,940 |
I/I |
53,500 |
845,800 |
1.5 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
10% Owner |
– – • |
2006-12-07 |
4 |
B |
$5.55 |
$1,865,910 |
I/I |
336,200 |
1,182,000 |
1.5 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
10% Owner |
– – • |
2006-12-11 |
4 |
B |
$6.16 |
$492,800 |
I/I |
80,000 |
1,262,000 |
1.5 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
10% Owner |
– – • |
2007-03-13 |
4 |
B |
$7.93 |
$365,414 |
I/I |
46,080 |
1,308,080 |
1.5 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
10% Owner |
– – • |
2007-03-14 |
4 |
B |
$7.91 |
$238,882 |
I/I |
30,200 |
522,460 |
1.5 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • • |
2007-05-30 |
4 |
B |
$9.17 |
$32,095,000 |
I/I |
3,500,000 |
3,500,000 |
2.25 |
- |
|
| CLDA |
Clinical Data Inc |
Director |
– • • |
2007-07-17 |
4 |
B |
$22.00 |
$49,500,000 |
I/I |
2,250,000 |
2,250,000 |
2.25 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • • |
2007-09-13 |
4 |
B |
$8.74 |
$574,332 |
I/I |
65,713 |
3,565,713 |
2.25 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • • |
2007-09-14 |
4 |
B |
$8.71 |
$1,112,206 |
I/I |
127,693 |
3,693,406 |
2.25 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • • |
2007-09-17 |
4 |
B |
$8.66 |
$2,061,253 |
I/I |
238,020 |
3,931,426 |
2.25 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • • |
2007-09-18 |
4 |
B |
$8.87 |
$137,387 |
I/I |
15,489 |
3,946,915 |
2.25 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • • |
2007-09-19 |
4 |
B |
$9.00 |
$207,765 |
I/I |
23,085 |
3,970,000 |
2.25 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • • |
2008-03-18 |
4 |
B |
$4.57 |
$948,485 |
I/I |
207,546 |
4,177,546 |
2.25 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • • |
2008-03-19 |
4 |
B |
$5.80 |
$5,142,570 |
I/I |
886,650 |
5,064,196 |
2.25 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • • |
2008-03-20 |
4 |
B |
$6.06 |
$7,704,901 |
I/I |
1,264,657 |
6,328,853 |
2.25 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • • |
2008-06-11 |
4 |
B |
$5.27 |
$608,364 |
I/I |
115,439 |
115,439 |
2.25 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • • |
2008-06-12 |
4 |
B |
$5.42 |
$308,940 |
I/I |
57,000 |
172,439 |
2.25 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • • |
2008-06-13 |
4 |
B |
$5.53 |
$252,859 |
I/I |
45,725 |
218,164 |
2.25 |
- |
|
271 Records found
|
|
Page 6 of 11 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
